Paul also posted this link from the instute responsible for the paper: https://www.cancerresearch.org/scientists/clinical-development/clinical-accelerator/landscape-of-immuno-oncology-drug-development End Points had a summary on it here: https://endpts.com/there-are-2004-cancer-immunotherapies-crowding-into-the-pipeline-now-what/